AxoGen (($AXGN)) announced an update on their ongoing clinical study. AxoGen’s ongoing clinical study, officially titled ‘A Multicenter, Registry ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback